The Fox Chase Chemical Diversity Center, Inc. (FCCDC)

 

Fox Chase Chemical Diversity Center Announces The Initiation Of A 5 Year U01 Grant With The Scripps Research Institute

 

Doylestown, PA. April 1, 2009 – The Fox Chase Chemical Diversity Center (FCCDC) today announced the initiation of a 5 year U01 grant with The Scripps Research Institute (TSRI), LaJolla, CA.  In support of the grant entitled Small Molecule Therapeutics for Botulinum Neurotoxin A (1 U01 AI082190-01), FCCDC serves as the medicinal chemistry arm of a large, multi-disciplinary consortium which seeks to identify and optimize novel ligands that inhibit the key zinc protease, BoNT/A, involved in the activity of botulinum toxin